MNV
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Noteworthy Thursday Option Activity: AI, AMBA, MRTX
Thursday, May 25, 4:47 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Sum Up The Parts: IWB Could Be Worth $262
Monday, June 5, 7:55 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Interesting MRTX Put And Call Options For July 21st
Wednesday, June 7, 10:49 AM ET, by Market News Video Staff

Investors in Mirati Therapeutics Inc (MRTX) saw new options become available this week, for the ...

Analysts Expect IYH To Hit $322
Thursday, July 6, 9:14 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Mirati Therapeutics Enters Oversold Territory (MRTX)
Friday, July 21, 11:45 AM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Top Buys by Directors: Hasnain's $300K Bet on MRTX

By Market News Video Staff, Monday, August 21, 2:28 PM ET
Play Video: One Reason For Insiders to Buy


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $300K by Faheem Hasnain, Director at Mirati Therapeutics Inc (NASDAQ:MRTX).

Hasnain bets big on MRTX:

Purchased Insider Title Shares Price/Share Value
08/11/2023 Faheem Hasnain Director 10,791 $27.80 $299,989.80

Hasnain's average cost works out to $27.80/share. Shares of Mirati Therapeutics Inc were changing hands at $37.65 at last check, trading down about 2.5% on Monday. The chart below shows the one year performance of MRTX shares, versus its 200 day moving average:

Mirati Therapeutics Inc Chart

Looking at the chart above, MRTX's low point in its 52 week range is $27.30 per share, with $101.30 as the 52 week high point — that compares with a last trade of $37.65.


Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.


This Article's Word Cloud:   Buys   Company   Days   Director   Directors   Dollars   Faheem   Hasnain   Insider   Join   Looking   MRTX   Mirati   Monday   Offer   Presumably   Price   Purchased   Seven   Share   Shares   Special   Start   Therapeutics   Title   Value   ValueForum   about   above   average   below   bets   both   business   buys   chart   company   directors   last   make   maybe   mdash   point   share   stock   take   that   they   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

Top Buys by Directors: Hasnain's $300K Bet on MRTX | Market News Video | Copyright © 2008 - 2024, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.

X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.